Prostaglandin E 2 (PGE 2 ) acts in synergy with other inflammatory stimuli such as tumor necrosis factor (TNF) to induce the maturation of migratory-type monocyte-derived dendritic cells (MoDCs). However, PGE 2 has been reported to inhibit IL-12p70 production by MoDCs and to promote the generation of Th2 T cell responses. We demonstrate here that the addition of PGE 2 to TNF for the maturation of MoDCs enhanced CD4 and CD8 T cell proliferative responses to neoantigen and recall antigen, and enhanced Th1-type responses. The increased stimulatory capacity of MoDCs matured with PGE 2 was associated with a fully mature, migratory-type MoDC phenotype and more rapid down-regulation of the expression of inflammatory chemokines, with up-regulated expression of the constitutive chemokines TARC and MDC. In addition, although MoDCs matured with TNF and PGE 2 selectively produced the inhibitory IL-12p40 subunit at steady state, they were able to produce the bioactive IL-12p70 heterodimer after stimulation with CD40 ligand and/or IFN-c. Despite increased IL-6 mRNA expression, MoDCs matured with PGE 2 did not overcome the suppressive effects of CD4 1 CD25 1 T cells in allogeneic mixed lymphocyte reactions. In conclusion, MoDCs matured in the presence of PGE 2 display characteristics of more efficient antigen-presenting cells that might be optimal for use in cancer vaccine-based clinical trials.
Introduction
Dendritic cells (DCs) are the most potent antigen-presenting cells (APCs). They are uniquely able to initiate naive T cell responses (1) . Following antigen uptake and processing, immature DCs undergo a maturation process, induced by inflammatory cytokines, bacterial or viral products, which leads to their migration to lymph nodes, where they efficiently attract and activate T cells (2, 3) . These properties justify their increasing interest as inducers of immune responses for cancer immunotherapy (4) . Several sources and multiple culture conditions for the maturation of human DCs have been described (5) (6) (7) (8) (9) (10) . An important goal in the field of immunotherapy is to determine the most potent source of DCs for the induction of CD4 and CD8 T cell-mediated immune responses.
Prostaglandin E 2 (PGE 2 ), an arachidonic acid metabolite (11) , is a common inflammatory mediator mainly produced by APCs. PGE 2 acts as an immunomodulator (12, 13) . It has been established that PGE 2 induces the terminal maturation of monocyte-derived dendritic cells (MoDCs) and increases the expression of MHC and co-stimulatory molecules, particularly when added to tumor necrosis factor (TNF) or a maturation cocktail containing TNF, IL-1b and IL-6 (14) (15) (16) (17) . MoDCs matured in the presence of PGE 2 enhance the proliferative response of allogeneic T cells (5, 9, 14, (16) (17) (18) . The level of production of the heterodimer IL-12p70 by DCs is the major determinant of their ability to promote T h 1 differentiation (19) . The bioactive IL-12p70 is composed of two subunits, p35 and p40. The p35 subunit, which is produced in lower amounts than p40, determines the amount of secreted IL-12p70 (20) . In contrast, p40 homodimers, and to a lesser extent p40 monomers, have been reported to inhibit the function of IL-12p70 by an antagonistic action on the IL-12R (21, 22) . The effects of PGE 2 on IL-12p70 production and T cell differentiation by human MoDCs are controversial (9, 14, 17, 18, (23) (24) (25) (26) (27) and remain to be clarified.
The trafficking of immature DCs to sites of inflammation and of mature DCs to the T cell area of secondary lymphoid organs is regulated by the expression, at the transcriptional level, of different chemokines and chemokine receptors (3, 28, 29) . Immature DCs express inflammatory chemokines (CCL2/ MCP-1, CCL3/MIP-1a, CCL4/MIP-1b, CCL5/RANTES and CCL20/MIP-3a) and chemokine receptors that bind to inflammatory chemokines (CCR1, CCR2, CCR5, CCR6 and CXCR1). On maturation, DCs down-regulate the inflammatory chemokines and their receptors and up-regulate constitutive chemokines such as CXCL10/IP-10, CCL17/TARC, CCL18/ PARC, CCL19/MIP-3b, CCL22/MDC and the chemokine receptor CCR7, ligand of the lymph node-derived chemokines CCL19/MIP-3b and CCL21/SLC. PGE 2 has been shown to upregulate CCR7 and CXCR4 on mature MoDCs and increase their migration to CCL19/MIP-3b and CCL21/SLC (17, 26) . However, the up-regulation of CCR7 mRNA expression by PGE 2 and TNF-matured MoDCs was not confirmed in another study (25) . Moreover, the effects of PGE 2 on chemokine production by MoDCs are unknown. Therefore, additional studies on the effect of PGE 2 on chemokine and chemokine receptor expression by MoDCs are required.
Accumulating evidence suggests that, in addition to their stimulatory properties, several subsets of human DCs can promote peripheral T cell tolerance by inducing the differentiation of T cells with regulatory properties, including CD4 + CD25 + T cells and T cells that produce immunosuppressive cytokines such as IL-10 and transforming growth factor-b. These subsets of human DCs include MoDCs at the immature stage of differentiation or after modulation by immunoregulatory cytokines (IL-10), drugs [1,25- (30) (31) (32) (33) (34) . In contrast, DCs activated by microbial induction of the Toll-like receptor pathway can block the suppressive effect of CD4 + CD25 + T cells, at least partially through the production of IL-6 (35). Whether or not PGE 2 -matured MoDCs influence the suppressive effects of CD4 + CD25 + T cells has not yet been investigated. In this study, we have further explored the characteristics of MoDCs matured in the presence of PGE 2 . We have analyzed their expression of chemokines and chemokine receptors and cytokine production following several stimuli, as well as their effects on the inhibitory functions of regulatory T cells.
Methods

Media, reagents and cell lines
The medium used for the generation of MoDCs was RPMI 1640 (Mediatech Cellgro, Herndon, VA, USA) supplemented with 10% heat-inactivated (30 min, 56°C) pooled human AB serum (Sigma, St Louis, MO, USA). Mixed lymphocyte reaction (MLR) medium consisted of AIM V (GIBCO, Grand Island, NY, USA) medium with 10% heat-inactivated (30 min, 56°C) pooled human AB serum, non-essential amino acids, L-glutamine, sodium pyruvate, penicillin-streptomycin (all from GIBCO), HEPES buffer (Fisher Biotech, Fair Lawn, NJ, USA) and 2-mercaptoethanol (2ME) (Sigma). FACS buffer was HBSS (Biowhittaker) containing 0.05% BSA and 0.01% sodium azide (NaN 3 ) (Sigma). Recombinant human (rh) IL-4 and granulocyte macrophage colony-stimulating factor (GM-CSF) were purchased from R&D Systems (Minneapolis, MN, USA), PGE 2 was purchased from Sigma and rhIFN-c was purchased from PharMingen (San Diego, CA, USA). Tetanus toxoid (TT) vaccine was purchased from Fort Dodge Laboratories (Fort Dodge, IA, USA). The content of the vaccine was dialyzed in PBS (Biowhittaker) for 24 h and concentrated with a Centricom filter (Millipore, Bedford, MA, USA). The final concentration was determined by the Bradford dye method (BioRad Laboratories, Hercules, CA, USA). Chicken IgG was purchased from Cappel Laboratories (West Chester, PA, USA). The CD40 ligand (CD40-L)-transfected NIH3T3 cell line (kindly provided by Hilda Ye, Albert Einstein College of Medicine, Bronx, NY, USA) was cultured in RPMI 1640 supplemented with 10% heat-inactivated FCS (Sigma), non-essential amino acids, L-glutamine, sodium pyruvate, penicillin-streptomycin, HEPES buffer and 2ME at 37°C in 7% CO 2 . CD40-L-transfected NIH3T3 cells were selected with 100 lg ml ÿ1 of Zeocin (Invitrogen, Carlsbad, CA, USA).
Isolation of human PBMC, monocytes, CD4
+ CD25 + and CD4 + CD25 ÿ T cells
All subjects donating blood for these experiments were healthy volunteers of both sexes, aged 25-50 years. PBMCs were isolated by standard density gradient centrifugation (400 3 g) on Ficoll HistopaqueÒ (Sigma). Monocytes and CD4 + T cells were isolated from PBMCs by negative selection using, respectively, the Monocyte Isolation Kit II and the CD4 + T Cell Isolation Kit II, purchased from Miltenyi Biotec (Auburn, CA, USA), according to the manufacturer's instructions. CD4 + CD25 + and CD4 + CD25 ÿ T cells were then separated from negatively selected CD4 + T cells using anti-CD25 microbeads (Miltenyi). The purities of the purified populations were >90% for monocytes and >80% for the CD4 + CD25 + and CD4 + CD25 ÿ cell populations (data not shown) based on the surface expression of CD14 and CD4 plus CD25, respectively.
Generation of human MoDCs
Immature MoDCs were generated by culturing monocytes (1.5 3 10 6 ml ÿ1 ) in the medium described above with rhGM-CSF (1000 U ml ÿ1 ) and rhIL-4 (700 U ml ÿ1 ) at 37°C in 7% CO 2 . RhTNF (1000 U ml ÿ1 ), with or without PGE 2 (3 lg ml ) were stimulated with 2 lg ml ÿ1 of PHA (GIBCO) and used as positive controls. Cells were incubated at 37°C in 7% CO 2 for 4-7 days.
Measurement of proliferation and cytokine production of responding T cells by flow cytometry T cell responses in cell cultures performed with CFSE-labeled responding cells were analyzed after 4-7 days of culture. Concomitant analysis of CFSE, T cell-surface markers and intracellular cytokine staining was performed directly or following a 6-h re-stimulation with 10 5 thawed MoDCs previously pulsed with the same antigen as that used in the stimulation phase before freezing in human AB serum with 10% dimethyl sulfoxide (both from Sigma). Control PHA blasts were stimulated for the last 4 h of culture with 100 nM phorbol myristate acetate and 1 lg ml ÿ1 ionomycin (both from Sigma). Brefeldin A (GolgiStop, PharMingen) (2 lg ml ÿ1 ) was added to each well for the last 4 h of incubation. Cells were then harvested and stained with PerCP-conjugated anti-CD3 (PharMingen) and allophycocyaninconjugated anti-CD4 or CD8 (PharMingen) in FACS buffer for 30 min at 4°C in a 96-well round-bottom plate. Mouse IgG1-peridinin-chlorophyll protein complex (PerCP) and mouse IgG1-allophycocyanin were used as isotype controls. In some experiments, cells were then washed twice in PBS and incubated in 100 ll Cytofix/Cytoperm solution (PharMingen) for 20 min in the dark, at room temperature. Fixed and permeabilized cells were washed twice with PermWash buffer (PharMingen) and stained with purified mouse anti-human IFN-c, TNF, IL-4, granzyme A and perforin (PharMingen) in the corresponding wells for 10 min at 4°C. PE-conjugated anti-IFN-c, TNF, IL-4 granzyme A and perforin (PharMingen) were added to the respective wells for 30 min at 4°C. Rat IgG2a-PE was used as a negative control. Cells were then washed in PermWash buffer and re-suspended in 100 ll FACS buffer. Alternatively, cells were washed in FACS buffer after the first step of surface staining and labeled with 0.5 lg of 7-amino-actinomycin-D (7-AAD) (Sigma) immediately before FCM analysis. A minimum of 30 000 events were acquired on a FACS Calibur flow cytometer and analyzed using Winlist software (Verity Software House, Topsham, ME, USA).
Measurement of surface antigen expression by flow cytometry (FCM)
Cell-surface staining was performed on 5 3 10 4 to 2 3 10 5 cells per sample. FITC-conjugated anti-CD3 and -CD19 and PE-labeled anti-CD56 and -CD14 (PharMingen) were used to evaluate the purity of monocytes, while anti-CD4-FITC and anti-CD25-PE mAbs (both purchased from PharMingen) were used to determine the purity of the CD4 + CD25 + and CD4 + CD25 ÿ populations. PE-conjugated anti-CCR5, CCR7 and CXCR4 mAbs (all purchased from PharMingen) were used to phenotype mature MoDCs. Non-reactive control mAbs HOPC-FITC (mouse IgG2a) and rat IgG2a-PE (prepared in our laboratory) were used as isotype controls. Exclusion of dead cells was performed by propidium iodide (PI) staining and gating on PI-negative cells. For most stains, 10 000 viable cells were analyzed on a FACS Calibur flow cytometer (Becton Dickinson, Mountain View, CA, USA) and further analysis was performed using Windows Multiple Document Interface(WinMDI) software (Scripps Research Institute, La Jolla, CA, USA).
RNA isolation and cDNA synthesis
Total RNA was extracted using the RNeasy kit according to the manufacturer's protocol (Qiagen, Valencia, CA, USA). Briefly, after DNase I (Invitrogen) treatment, 1 lg of total RNA from each sample was used as template for the reverse transcription (RT) reaction. One hundred microliters of cDNA was synthesized using oligo(dT)15, random hexamers and multiscribe reverse transcriptase (Applied Biosystems, Foster City, CA, USA). All samples were reverse transcribed under the same conditions (25°C for 10 min and 48°C for 30 min) and from the same RT master mix to minimize differences in RTefficiency.
Quantitative real-time reverse transcription-PCR
Primer sequences for quantitative PCR (QPCR) were previously described (36) . The 25-ll QPCR mixture contains 2 ll of cDNA, 12.5 ll of 23 SYBR Green master mix (Stratagene, La Jolla, CA, USA) and 250 nmol of sense and anti-sense primer. The reaction conditions were as follows: 50°C for 2 min, 95°C for 10 min and then 40 cycles of 95°C for 15 s and 60°C for 1 min. Emitted fluorescence for each reaction was measured during the annealing/extension phase, and amplification plots were analyzed using the MX4000 software version 3.0 (Stratagene). A series of standards was prepared by performing 10-fold serial dilutions of full-length cDNAs in the range of 20 million copies to 2 copies per QPCR. Subsequent analysis was performed on the data output from the MX4000 software using Excel XP (Microsoft, Redmond, WA, USA). The threshold cycle, i.e. the cycle number at which the amount of amplified gene of interest reaches threshold fluorescence, was determined by using the adaptive baseline algorithm in the MX4000 analysis software. This algorithm sets the threshold cycle at 10 standard deviations (SDs) above the background fluorescence between cycles 5 through 9. Quantity values (i.e. copies) for gene expression were generated by comparison of the fluorescence generated by each sample with standard curves of known quantities. Next, the calculated number of copies was divided by the number of copies of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In addition, we saw no significant changes in the QPCR results when the data were normalized using another constitutively active gene, b 2 -microglobulin.
Cytokine assays
Cytokine production by immature MoDCs was analyzed on supernatants collected on Day 5 of culture and stored at ÿ80°C. Two days later, the same MoDCs, matured in the presence or absence of PGE 2 , were extensively washed in MLR media. Mature MoDCs (5 3 10 5 ) were then incubated with media alone or with 1000 IU ml ÿ1 of rh IFN-c alone or with 1.25 3 10 5 CD40-L-transfected NIH3T3 cells (referred to as L-cells) with or without 1000 IU ml ÿ1 of rh IFN-c in 1 ml of MLR media, in a 48-well plate at 37°C in 7% CO 2 . In addition, control wells containing 1.25 3 10 5 L-cells with or without 1000 IU ml ÿ1 of rh IFN-c were plated in the same conditions. After 48 h of stimulation, supernatants were collected and stored at ÿ80°C. Cytokine concentrations were measured using specific ELISA kits for human IL-12p40, IL-12p70 and IL-10 purchased from R&D Systems, according to the manufacturer's instructions. Fig. 2A and data not shown) . Thus, further analysis was focused on the production of these molecules by dividing T cells.
T cell proliferation assays
Granzyme A, perforin and cytokine production by CD3 + CD4 + and CD3 + CD8 + T cell responses to TT on Day 7 of MLR is shown in Fig. 2(B) . These were compared with the background of the few dividing T cells stimulated with non-pulsed MoDCs (data not shown). (Fig. 2B) . However, these responding CD8 + T cells produced molecules involved in cytotoxic function, including granzyme A and perforin, at higher levels than control CD8 + T cells stimulated with nonpulsed MoDCs (Fig. 2B and data not shown) . Cytokine production by divided CD4 and CD8 T cells in response to neoantigen (chicken IgG) was similar to that in response to recall antigen (data not shown). Thus, PGE 2 -matured MoDCs efficiently induced the differentiation of antigen-specific T h 1 cytokine-producing CD4 + T cells and the activation of antigenspecific cytotoxic effector CD8 + T cells.
PGE 2 enhances the maturation of MoDCs
We next assessed the effect of PGE 2 on the acquisition of MoDC maturation characteristics. In concordance with published results (18, 20) , we observed that MoDCs matured with TNF and PGE 2 expressed higher levels of MHC class I and II, co-stimulatory molecules (CD80 and CD86) and the maturation marker CD83 than MoDCs matured with TNF alone (data not shown). We also analyzed the expression of chemokine receptors that have been associated with the maturation of MoDCs. We used QPCR to examine the mRNA expression of CCR5, CXCR4 and CCR7 in immature MoDCs before and at several time points following the induction of maturation with or without PGE 2 . These results were compared by flow cytometry to analyze surface expression of these chemokine receptors on MoDCs matured for 48 h. Compared with non-PGE 2 -matured MoDCs, those matured with PGE 2 showed more rapid down-regulation of CCR5 and increased upregulation of CXCR4 and CCR7 at the mRNA level (Fig. 3A) .
In accordance with these results, surface expression of CCR5 was decreased, while surface expression of CXCR4 was increased on MoDCs matured with PGE 2 compared with those matured with TNF alone. However, no increase in surface expression of CCR7 was detected on PGE 2 -matured MoDCs at 48 h (Fig. 3B) .
Because chemokine mRNA expression is altered by the maturation of MoDCs (29), we examined the effect of PGE 2 on the expression of inflammatory and constitutive chemokines by QPCR in MoDCs before and after maturation. In comparison to MoDCs matured without PGE 2 , MoDCs matured in the presence of PGE 2 showed a more rapid decline in the expression of mRNA for the inflammatory chemokines CCL2/ MCP-1, CCL3/MIP-1a, CCL4/MIP-1b and CCL5/RANTES (Fig. 4A) but showed a more stable expression of the constitutive chemokine CCL22/MDC and markedly greater induction of CCL17/TARC mRNA (Fig. 4B) . However, MoDCs matured with or without PGE 2 did not up-regulate CXCL9/MIG, CXCL10/IP-10, CXCL11/I-TAC or CCL11/eotaxin-1 mRNA species (Fig. 4B ).
Differential effects of PGE 2 on the production of cytokines by MoDCs during maturation, at steady state and after stimulation with CD40-L and/or IFN-c
We compared the production of cytokines by MoDCs matured with or without PGE 2 and by immature MoDCs. We first analyzed the production of a series of cytokines using QPCR. As shown in Fig. 5(A) , compared with non-PGE 2 -matured MoDCs, those that were matured in the presence of PGE 2 down-regulated IL-10 and TNF more rapidly and showed similar expression of IL-1b, but showed greater induction of IL-6 and IL-12p40 mRNA. As expected, no expression of IL-4, IL-5, IL-13 or IFN-c mRNA was detectable in either type of MoDCs.
We then investigated the capacity of PGE 2 -matured versus non-PGE 2 -matured MoDCs to produce IL-10, IL-12p40 and IL-12p70 protein and compared these results with those obtained with immature MoDCs. Cytokines were measured in the supernatants of immature MoDCs on Day 5 of differentiation and of non-PGE 2 -and PGE 2 -matured MoDCs cultured for 48 additional hours with or without CD40-L and/or IFN-c. Results are shown in Fig. 5(B) . The production of IL-10 by unstimulated, mature MoDCs was increased for MoDCs matured with PGE 2 in comparison with those matured without PGE 2 (43.7 6 6.8 and 8.7 6 10 pg ml ÿ1 , respectively, P < 0.04). However, PGE 2 did not significantly modulate the production of IL-10 by MoDCs after stimulation by IFN-c, CD40-L or both, and the levels of IL-10 did not increase with the maturation and stimulation of MoDCs. The production of IL-12p40, which begins when maturation of MoDCs commences, was significantly increased among unstimulated MoDCs matured with PGE 2 compared with those matured without PGE 2 (1273 6 44 and 55 6 33 pg ml ÿ1 , respectively, P < 0.05), confirming the results obtained at the mRNA level. Similar results were obtained when MoDCs were stimulated with IFN-c alone (1455 6 21 pg ml ÿ1 with PGE 2 and 220 6 19 pg ml ÿ1 without PGE 2 , P < 0.05). However, following stimulation by CD40-L or CD40-L and IFN-c, the production of IL-12p40 by MoDCs matured with PGE 2 was significantly lower than that of MoDC matured without PGE 2 (9600 6 160 versus 13 880 6 167 pg ml ÿ1 and 11 623 6 136 versus 17 073 6 104 pg ml ÿ1 , respectively, P < 0.05). The supernatant levels of IL-12p70, which were significantly lower than those of IL-12p40, were up-regulated by CD40-L, and were markedly increased by the combination of CD40-L and IFN-c. Under such stimulation conditions, MoDCs matured with PGE 2 showed decreased production of IL-12p70 compared with MoDCs matured without PGE 2 (19 6 2 versus 31 6 1.5 pg ml ÿ1 and 203 6 10 versus 278 6 24 pg ml ÿ1 , respectively, P < 0.05). However, the ratio of IL-12p40/ IL-12p70 was similar between MoDCs matured with or without PGE 2 following stimulation with CD40-L and IFN-c (57 versus 61, respectively). (Fig. 6B) .
MoDCs matured with PGE
Discussion
The effective use of DCs for cancer immunotherapy will require a detailed understanding of their immunological properties. MoDCs are currently the major source of DCs used in clinical vaccination protocols for the treatment of cancer (38, 39) . In vivo, matured human MoDCs have been shown to be more efficient than immature MoDCs in inducing specific anti-tumor antigen proliferative and cytotoxic T cell responses (40) . PGE 2 is known to induce terminal maturation of human MoDCs in synergy with other inflammatory stimuli (5, 16, (18) (19) (20) 25) . However, whether or not PGE 2 -matured MoDCs are more efficient APCs for cancer immunotherapy is still the subject of debate and required further investigation. This study further analyzes the immunological characteristics of human MoDCs matured in the presence or absence of PGE 2 .
As reported by others (5, 9, 18-20), we observed that PGE 2 -matured MoDCs enhanced T cell proliferative responses to alloantigens (data not shown). In addition, we provide the first demonstration that MoDC maturation in PGE 2 enhances CD4 + and CD8 + T cell responsiveness to exogenous protein antigens, including recall antigens (TT) and neoantigens (chicken IgG). Both more rapid and increased recruitment of antigen-specific CD4 + and CD8 + precursor T cells was achieved with PGE 2 -matured MoDC, and this was not due to increased activation-induced death of T cells activated by MoDCs matured without PGE 2 . The mechanisms involved in the improved responses to recall and neoantigens to CD8 cells remain to be determined. These might be due to enhanced cross-presentation of exogenous antigens by class I molecules or increased CD4 + T cell-or NK-mediated help to CD8 + T cells in the presence of MoDCs matured with PGE 2 . Regardless of the mechanism, this observation has important implications for the generation of tumor antigen-specific CTLs.
The polarization of T cells toward Th1 or Th2 responses is essential in determining the final outcome of immune responses (41) . The differentiation of T cells toward Th1 or Th2 by human DCs was initially reported to be determined by the subset of DCs: myeloid DCs (DC1), now known to be MoDCs, were reported to induce Th1 responses, while lymphoid/plasmacytoid DCs (DC2) induce Th2 responses (42) . More recently, however, MoDCs inducing Th2 responses have been described (43) and the concept that Th polarization promoted by DCs depends on their culture conditions and activation signals has emerged (44, 45) . Our studies demonstrate that PGE 2 -matured MoDCs induce the differentiation of Th1, antigen-specific, CD4
+ and CD8 + T cells. Indeed, antigen-activated CD4 + T cells displayed a phenotype of Th1 cells, producing IFN-c (and also TNF), with no IL-4. TT-specific CD8 + T cells did not produce very high levels of IFN-c, but did express molecules associated with cytotoxic effector differentiation. Consistent with several other reports (16, 19, 20, (25) (26) (27) 46) , similar results were obtained when we explored alloantigen-specific T cell responses (data not shown). However, our results contrast with those of Kalinski and colleagues (17, 44, 47, 48) , who showed that MoDCs matured with PGE 2 induced the differentiation of Th2 cytokine-producing T cell responses. The differing results cannot be readily explained by differences in culture conditions or activation signals, as these were similar to those in our studies and those of other groups with results consistent with our own. The discrepancy might best be explained by the type of T cell response explored and the signals used to induce cytokine production by activated T cells. Kalinski and colleagues studied naive T cell responses to superantigens after two stimulations with autologous MoDCs and explored the cytokine production of T cells activated non-specifically via CD3 and CD28 mAbs. We explored responses of naive and/or memory T cells to TT protein antigens and analyzed the cytokine production of activated T cells after a short 6-h restimulation with MoDC presenting the same antigen. This approach addressed the cytokine responses of T cells activated by specific antigens, which may be closer to the in vivo situation of cancer patients, in whom the objective of vaccination with MoDCs-bearing tumor antigens is to break the tolerance of patient T cells against the tumor and achieve tumor antigen-specific cytotoxic responses.
Mature DCs are specialized in the activation of T cells because of their high expression of MHC and co-stimulatory molecules, and also because of the acquisition of chemokine receptors allowing their migration to the Tcell area of the lymph node and the production of chemokine-attracting T cells. Thus, analysis of these characteristics is important for an understanding of their in vivo T cell stimulatory potential. As previously described (16) (17) (18) (19) , we confirmed that PGE 2 increased the expression of MHC class I and II, CD80, CD86 and CD83 molecules on matured MoDCs (data not shown). In addition, PGE 2 -matured MoDCs completely lost CCR5 expression and showed significantly greater up-regulation of CXCR4 and CCR7 mRNA than MoDC matured without PGE 2 . While contrasting with the results of Lee et al. (25) , our results confirm those of Luft et al. (26) and Scandella et al. (19) , who both showed that these phenotypic characteristics are associated with increased migratory capacity.
We also observed that PGE 2 regulates the kinetics and the level of chemokine mRNA expression by MoDCs. PGE 2 accelerated the down-regulation of the pro-inflammatory chemokines CCL2/MCP-1, CCL3/MIP-1a, CCL4/MIP-1b and CCL5/RANTES and induced 2-to 4-fold increases in the expression of the constitutively expressed chemokines CCL22/MDC and CCL17/TARC on mature MoDCs. These results consolidate the role of PGE 2 in accelerating the maturation of MoDCs and suggest that the greater and more rapid stimulatory capacity of MoDCs matured with PGE 2 might be due to an increased ability to attract T cells. Consistent with this hypothesis, we and others have observed increased DC-T cell interaction in culture as shown by increased number and size of clumps when DCs were matured in the presence of PGE 2 (data not shown) (18) . However, in contrast to LPSmatured MoDCs (29, 49) , mRNA for chemokines that preferentially attract T h 1 T cells, such as CXCL9/MIG, CXCL10/IP-10 and CXCL11/I-TAC (50), was not detectable in MoDCs matured with TNF, regardless of the presence or absence of PGE 2 . Instead, PGE 2 -matured MoDCs expressed high levels of CCL22/MDC and CCL17/TARC, which are ligands for CCR4, a chemokine receptor preferentially expressed on T h 2 T cells (50, 51) . These results might explain the higher T h 2 cytokine production by non-specifically activated T cells in the presence of PGE 2 -matured MoDCs, as reported by Kalinski et al. (17, 44, 47, 48) . We and others (16, 19, 20, (25) (26) (27) , however, observed the differentiation of T h 1 T cells by MoDCs matured with PGE 2 . Taken together, these results suggest that CCL17/TARC and CCL22/MDC can attract CCR4-expressing T cells with both T h 2 and T h 1 potentials and that the polarization of the final T cell response is mainly determined by additional environmental factors and signals.
DCs control T cell responses by the production of cytokines. MoDC-derived IL-12p70 is the major T h 1-driving factor (21), while IL-10 inhibits the stimulatory capacity of DCs and impairs DC-mediated T h 1 T cell differentiation, promoting T h 2 differentiation and T cell anergy (52, 53) . We showed that MoDCs matured with TNF, with or without PGE 2 , produced very low levels of IL-12p70 in the absence of additional stimulation by IFN-c and CD40-L, the combination of which led to maximal production of this cytokine. These results are in agreement with other studies showing that only MoDCs matured in the presence of fixed bacteria (Escherichia coli ), bacterial products (LPS, Staphylococcus aureus Cowan I) or poly (inosinic acid)-poly(cytidylic acid) can produce IL-12p70 without further activation (8, 21, 47) , while MoDCs matured under other conditions required either high levels of CD40 cross-linking (54) or the combination of CD40-L and IFN-c to produce optimal levels of IL-12p70 (55) . Our studies demonstrated that PGE 2 regulates the production by MoDCs of both IL-12p70 and IL-12p40. PGE 2 selectively enhanced the production of IL-12p40 by unstimulated or IFN-c-stimulated MoDCs, but reduced IL-12p40 and IL-12p70 production by MoDCs stimulated by CD40-L, with or without IFN-c. Thus, we believe that the previous observation (56) that PGE 2 selectively induces the production of IL-12p40 by MoDCs applies only to non-stimulated or IFN-c-stimulated MoDCs. In contrast, when MoDCs were stimulated by CD40-L and IFN-c, which occurs during the interaction between DCs and CD4 T h (57), PGE 2 -matured MoDCs were able to produce, although at lower levels, both IL-12p70 and IL-12p40. Importantly, the ratio of IL-12p40/IL-12p70 was similar in supernatants from MoDCs matured with or without PGE 2 . In addition, PGE 2 did not influence the production of IL-10 by MoDCs, which was downregulated during their maturation and maintained at very low levels following stimulation by CD40-L and IFN-c. Together, these data suggest that PGE 2 -matured MoDCs are likely to produce very low amounts of IL-10 but significant levels of IL-12p70 in response to their interaction with T cells, and can therefore induce T h 1-polarized T cell responses. The physiological significance of high production levels of IL-12p40, in particular by unstimulated PGE 2 -matured MoDCs, is unknown. It has recently been shown that IL-12p40 can associate with IL-23p19 (58) . Signaling through IL-23R induces the production of IFN-c and IL-17 by memory T cells (58, 59) . (46) . Further investigations are required to explore this hypothesis.
In conclusion, the addition of PGE 2 to TNF to achieve the maturation of human MoDCs induces the generation of migratory-type MoDCs that express high levels of T cellattracting chemokines, MHC and co-stimulatory molecules, and that produce IL-12p70 but not IL-10 after stimulation with CD40-L and IFN-c. These properties are associated with increased stimulatory capacity and the promotion of T h 1 antigen-specific Tcell responses. Thus, MoDCs matured in the presence of PGE 2 display the characteristics of efficient APCs that should be considered as a potential source of APCs in anti-cancer vaccine trials.
